Structure

Physi-Chem Properties

Molecular Weight:  562.28
Volume:  565.294
LogP:  3.09
LogD:  2.437
LogS:  -3.501
# Rotatable Bonds:  8
TPSA:  166.14
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.163
Synthetic Accessibility Score:  4.998
Fsp3:  0.633
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.994
MDCK Permeability:  5.1987448387080804e-05
Pgp-inhibitor:  0.057
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.882
20% Bioavailability (F20%):  0.049
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.077
Plasma Protein Binding (PPB):  94.8222427368164%
Volume Distribution (VD):  0.571
Pgp-substrate:  5.714666843414307%

ADMET: Metabolism

CYP1A2-inhibitor:  0.051
CYP1A2-substrate:  0.026
CYP2C19-inhibitor:  0.018
CYP2C19-substrate:  0.172
CYP2C9-inhibitor:  0.046
CYP2C9-substrate:  0.093
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.096
CYP3A4-inhibitor:  0.07
CYP3A4-substrate:  0.181

ADMET: Excretion

Clearance (CL):  5.103
Half-life (T1/2):  0.866

ADMET: Toxicity

hERG Blockers:  0.546
Human Hepatotoxicity (H-HT):  0.246
Drug-inuced Liver Injury (DILI):  0.036
AMES Toxicity:  0.041
Rat Oral Acute Toxicity:  0.567
Maximum Recommended Daily Dose:  0.957
Skin Sensitization:  0.645
Carcinogencity:  0.029
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.907

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC204644

Natural Product ID:  NPC204644
Common Name*:   9Beta-O-(E-P-Hydroxycinnamoyl)-1Beta,6Beta-Dihydroxy-Trans-Eudesm-3-En-6-O-Beta-D-Glucopyranoside
IUPAC Name:   [(1S,3S,4R,4aS,8R,8aR)-8-hydroxy-5,8a-dimethyl-3-propan-2-yl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,4a,7,8-hexahydro-1H-naphthalen-1-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  FYIRTYWAWSCPCM-RQDXIEOQSA-N
Standard InCHI:  InChI=1S/C30H42O10/c1-15(2)19-13-22(39-23(34)12-8-17-6-9-18(32)10-7-17)30(4)21(33)11-5-16(3)24(30)28(19)40-29-27(37)26(36)25(35)20(14-31)38-29/h5-10,12,15,19-22,24-29,31-33,35-37H,11,13-14H2,1-4H3/b12-8+/t19-,20+,21+,22-,24+,25+,26-,27+,28+,29-,30+/m0/s1
SMILES:  CC(C)[C@@H]1C[C@@H]([C@@]2(C)[C@@H](CC=C(C)[C@@H]2[C@@H]1O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)OC(=O)/C=C/c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2011643
PubChem CID:   57333878
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23708 Aster koraiensis Species Asteraceae Eukaryota aerial parts Euidang-myun, Gongju city, Chungchengnam-do, Republic of Korea 2007-Aug PMID[22264115]
NPO23708 Aster koraiensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT35 Others n.a. IC50 > 50000.0 nM PMID[479575]
NPT68 Individual Protein Aldose reductase Rattus norvegicus IC50 > 30000.0 nM PMID[479575]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC204644 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9362 High Similarity NPC320734
0.9028 High Similarity NPC470330
0.8912 High Similarity NPC77310
0.8905 High Similarity NPC235294
0.8905 High Similarity NPC46137
0.8819 High Similarity NPC96447
0.8768 High Similarity NPC225384
0.8768 High Similarity NPC138777
0.8768 High Similarity NPC246869
0.875 High Similarity NPC288416
0.8732 High Similarity NPC197316
0.8732 High Similarity NPC64141
0.8732 High Similarity NPC472350
0.8732 High Similarity NPC476383
0.8732 High Similarity NPC68092
0.8732 High Similarity NPC89105
0.8732 High Similarity NPC81515
0.8716 High Similarity NPC116292
0.8716 High Similarity NPC87630
0.8716 High Similarity NPC179128
0.8716 High Similarity NPC267469
0.8693 High Similarity NPC269668
0.8676 High Similarity NPC471157
0.8671 High Similarity NPC470617
0.8671 High Similarity NPC470616
0.8667 High Similarity NPC474532
0.8662 High Similarity NPC260425
0.8652 High Similarity NPC263829
0.8633 High Similarity NPC478255
0.8613 High Similarity NPC106677
0.8611 High Similarity NPC47471
0.8611 High Similarity NPC476377
0.8611 High Similarity NPC476385
0.8611 High Similarity NPC134405
0.8603 High Similarity NPC126991
0.8603 High Similarity NPC83218
0.8601 High Similarity NPC205195
0.8601 High Similarity NPC116742
0.8601 High Similarity NPC139243
0.8592 High Similarity NPC154485
0.8592 High Similarity NPC471872
0.8591 High Similarity NPC162569
0.8591 High Similarity NPC35160
0.8582 High Similarity NPC34293
0.8582 High Similarity NPC886
0.8582 High Similarity NPC287597
0.8552 High Similarity NPC265648
0.8552 High Similarity NPC222433
0.8551 High Similarity NPC225307
0.8543 High Similarity NPC471874
0.8542 High Similarity NPC475530
0.8542 High Similarity NPC473799
0.8542 High Similarity NPC164743
0.854 High Similarity NPC252114
0.8535 High Similarity NPC469459
0.8535 High Similarity NPC469458
0.8535 High Similarity NPC88176
0.8535 High Similarity NPC149002
0.8535 High Similarity NPC469396
0.8531 High Similarity NPC476376
0.8531 High Similarity NPC78363
0.8519 High Similarity NPC52097
0.8493 Intermediate Similarity NPC298257
0.8493 Intermediate Similarity NPC96795
0.8493 Intermediate Similarity NPC476384
0.8493 Intermediate Similarity NPC112
0.8493 Intermediate Similarity NPC119537
0.8493 Intermediate Similarity NPC247032
0.8493 Intermediate Similarity NPC476380
0.8493 Intermediate Similarity NPC175214
0.8493 Intermediate Similarity NPC76406
0.8493 Intermediate Similarity NPC476375
0.8493 Intermediate Similarity NPC269141
0.8493 Intermediate Similarity NPC264632
0.8493 Intermediate Similarity NPC476381
0.8493 Intermediate Similarity NPC476378
0.8493 Intermediate Similarity NPC476397
0.8493 Intermediate Similarity NPC205864
0.8478 Intermediate Similarity NPC471882
0.8478 Intermediate Similarity NPC45224
0.8478 Intermediate Similarity NPC471881
0.8478 Intermediate Similarity NPC156692
0.8478 Intermediate Similarity NPC173150
0.8478 Intermediate Similarity NPC230331
0.8478 Intermediate Similarity NPC35288
0.8472 Intermediate Similarity NPC321184
0.8472 Intermediate Similarity NPC321638
0.8472 Intermediate Similarity NPC328273
0.8472 Intermediate Similarity NPC171134
0.8467 Intermediate Similarity NPC12006
0.8456 Intermediate Similarity NPC95990
0.8451 Intermediate Similarity NPC169398
0.8446 Intermediate Similarity NPC208293
0.8444 Intermediate Similarity NPC11724
0.844 Intermediate Similarity NPC473285
0.8435 Intermediate Similarity NPC26045
0.8435 Intermediate Similarity NPC296659
0.8435 Intermediate Similarity NPC202391
0.8435 Intermediate Similarity NPC300894
0.8435 Intermediate Similarity NPC141455
0.8435 Intermediate Similarity NPC296954
0.8435 Intermediate Similarity NPC196063
0.8435 Intermediate Similarity NPC251062
0.8435 Intermediate Similarity NPC64195
0.8435 Intermediate Similarity NPC184464
0.8421 Intermediate Similarity NPC257847
0.8418 Intermediate Similarity NPC469419
0.8414 Intermediate Similarity NPC271494
0.8414 Intermediate Similarity NPC473591
0.8414 Intermediate Similarity NPC155192
0.8406 Intermediate Similarity NPC61181
0.8403 Intermediate Similarity NPC65262
0.8403 Intermediate Similarity NPC469364
0.8403 Intermediate Similarity NPC101686
0.8397 Intermediate Similarity NPC117943
0.8397 Intermediate Similarity NPC477627
0.8397 Intermediate Similarity NPC293568
0.8394 Intermediate Similarity NPC265413
0.8394 Intermediate Similarity NPC10154
0.8392 Intermediate Similarity NPC476870
0.8389 Intermediate Similarity NPC97240
0.838 Intermediate Similarity NPC28637
0.8378 Intermediate Similarity NPC100998
0.8378 Intermediate Similarity NPC34927
0.8378 Intermediate Similarity NPC252292
0.8378 Intermediate Similarity NPC34587
0.8378 Intermediate Similarity NPC476382
0.837 Intermediate Similarity NPC476872
0.8369 Intermediate Similarity NPC254819
0.8367 Intermediate Similarity NPC235557
0.8367 Intermediate Similarity NPC105005
0.8365 Intermediate Similarity NPC286809
0.8357 Intermediate Similarity NPC477293
0.8357 Intermediate Similarity NPC477294
0.8357 Intermediate Similarity NPC86257
0.8357 Intermediate Similarity NPC229784
0.8356 Intermediate Similarity NPC27518
0.8356 Intermediate Similarity NPC304110
0.8355 Intermediate Similarity NPC478268
0.8345 Intermediate Similarity NPC182249
0.8345 Intermediate Similarity NPC103533
0.8333 Intermediate Similarity NPC470733
0.8323 Intermediate Similarity NPC135334
0.8323 Intermediate Similarity NPC469777
0.8323 Intermediate Similarity NPC469778
0.8323 Intermediate Similarity NPC32723
0.8323 Intermediate Similarity NPC469774
0.8323 Intermediate Similarity NPC469773
0.8323 Intermediate Similarity NPC469776
0.8323 Intermediate Similarity NPC100925
0.8323 Intermediate Similarity NPC477617
0.8323 Intermediate Similarity NPC469775
0.8323 Intermediate Similarity NPC148185
0.8323 Intermediate Similarity NPC295941
0.8323 Intermediate Similarity NPC469772
0.8322 Intermediate Similarity NPC471883
0.8322 Intermediate Similarity NPC229505
0.8321 Intermediate Similarity NPC470815
0.8313 Intermediate Similarity NPC471870
0.8311 Intermediate Similarity NPC25491
0.8309 Intermediate Similarity NPC469686
0.8299 Intermediate Similarity NPC296643
0.8299 Intermediate Similarity NPC140502
0.8299 Intermediate Similarity NPC145319
0.8286 Intermediate Similarity NPC232880
0.8282 Intermediate Similarity NPC475613
0.8276 Intermediate Similarity NPC22676
0.8276 Intermediate Similarity NPC475482
0.8276 Intermediate Similarity NPC216940
0.8276 Intermediate Similarity NPC198621
0.8269 Intermediate Similarity NPC478269
0.8267 Intermediate Similarity NPC232992
0.8255 Intermediate Similarity NPC286245
0.8255 Intermediate Similarity NPC138915
0.8255 Intermediate Similarity NPC272619
0.8252 Intermediate Similarity NPC254398
0.8243 Intermediate Similarity NPC186296
0.8243 Intermediate Similarity NPC40305
0.8239 Intermediate Similarity NPC473047
0.8239 Intermediate Similarity NPC219677
0.8239 Intermediate Similarity NPC265600
0.8235 Intermediate Similarity NPC469704
0.8235 Intermediate Similarity NPC201402
0.8235 Intermediate Similarity NPC469703
0.8235 Intermediate Similarity NPC160854
0.8231 Intermediate Similarity NPC7518
0.8231 Intermediate Similarity NPC159387
0.8231 Intermediate Similarity NPC475513
0.8231 Intermediate Similarity NPC137501
0.8231 Intermediate Similarity NPC473755
0.8231 Intermediate Similarity NPC154262
0.8227 Intermediate Similarity NPC253595
0.8219 Intermediate Similarity NPC475757
0.8219 Intermediate Similarity NPC49597
0.8219 Intermediate Similarity NPC474640
0.8214 Intermediate Similarity NPC476873
0.821 Intermediate Similarity NPC13989
0.8207 Intermediate Similarity NPC166180
0.8207 Intermediate Similarity NPC471345
0.8207 Intermediate Similarity NPC249817

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC204644 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8732 High Similarity NPD7266 Discontinued
0.7815 Intermediate Similarity NPD8166 Discontinued
0.7697 Intermediate Similarity NPD7228 Approved
0.7692 Intermediate Similarity NPD1653 Approved
0.7632 Intermediate Similarity NPD6674 Discontinued
0.7562 Intermediate Similarity NPD8455 Phase 2
0.7544 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD8313 Approved
0.7529 Intermediate Similarity NPD8312 Approved
0.75 Intermediate Similarity NPD37 Approved
0.7485 Intermediate Similarity NPD6234 Discontinued
0.7469 Intermediate Similarity NPD4967 Phase 2
0.7469 Intermediate Similarity NPD4965 Approved
0.7469 Intermediate Similarity NPD4966 Approved
0.7468 Intermediate Similarity NPD4628 Phase 3
0.7466 Intermediate Similarity NPD5736 Approved
0.7448 Intermediate Similarity NPD3094 Phase 2
0.744 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD7458 Discontinued
0.7419 Intermediate Similarity NPD6190 Approved
0.7417 Intermediate Similarity NPD7097 Phase 1
0.7394 Intermediate Similarity NPD8127 Discontinued
0.7394 Intermediate Similarity NPD5126 Approved
0.7394 Intermediate Similarity NPD5125 Phase 3
0.7355 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4060 Phase 1
0.731 Intermediate Similarity NPD7240 Approved
0.731 Intermediate Similarity NPD7685 Pre-registration
0.731 Intermediate Similarity NPD6559 Discontinued
0.7303 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD1091 Approved
0.7292 Intermediate Similarity NPD3092 Approved
0.7273 Intermediate Similarity NPD5763 Approved
0.7273 Intermediate Similarity NPD5762 Approved
0.7267 Intermediate Similarity NPD6663 Approved
0.7235 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD4140 Approved
0.7216 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD8150 Discontinued
0.72 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD7074 Phase 3
0.7176 Intermediate Similarity NPD7799 Discontinued
0.7171 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD5124 Phase 1
0.716 Intermediate Similarity NPD4380 Phase 2
0.7143 Intermediate Similarity NPD8651 Approved
0.7135 Intermediate Similarity NPD5844 Phase 1
0.7135 Intermediate Similarity NPD7054 Approved
0.7133 Intermediate Similarity NPD3091 Approved
0.7125 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD2861 Phase 2
0.7108 Intermediate Similarity NPD7075 Discontinued
0.7102 Intermediate Similarity NPD8434 Phase 2
0.7093 Intermediate Similarity NPD7472 Approved
0.7086 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD4908 Phase 1
0.7063 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5735 Approved
0.7048 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD7157 Approved
0.7034 Intermediate Similarity NPD4626 Approved
0.7027 Intermediate Similarity NPD7435 Discontinued
0.702 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD7095 Approved
0.702 Intermediate Similarity NPD3027 Phase 3
0.7019 Intermediate Similarity NPD6273 Approved
0.7011 Intermediate Similarity NPD7251 Discontinued
0.7 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.6993 Remote Similarity NPD3620 Phase 2
0.6993 Remote Similarity NPD1613 Approved
0.6993 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6993 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6989 Remote Similarity NPD8319 Approved
0.6989 Remote Similarity NPD8320 Phase 1
0.6982 Remote Similarity NPD7199 Phase 2
0.6977 Remote Similarity NPD3818 Discontinued
0.6974 Remote Similarity NPD3764 Approved
0.6971 Remote Similarity NPD7808 Phase 3
0.6966 Remote Similarity NPD5691 Approved
0.6966 Remote Similarity NPD7503 Approved
0.6962 Remote Similarity NPD1652 Phase 2
0.6961 Remote Similarity NPD6534 Approved
0.6961 Remote Similarity NPD6535 Approved
0.6957 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6954 Remote Similarity NPD6797 Phase 2
0.6951 Remote Similarity NPD7028 Phase 2
0.6948 Remote Similarity NPD6355 Discontinued
0.694 Remote Similarity NPD7699 Phase 2
0.694 Remote Similarity NPD7700 Phase 2
0.6937 Remote Similarity NPD7236 Approved
0.6937 Remote Similarity NPD5058 Phase 3
0.6928 Remote Similarity NPD7819 Suspended
0.6928 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4198 Discontinued
0.6918 Remote Similarity NPD7003 Approved
0.6918 Remote Similarity NPD2932 Approved
0.6918 Remote Similarity NPD3095 Discontinued
0.6918 Remote Similarity NPD3750 Approved
0.6914 Remote Similarity NPD8368 Discontinued
0.6902 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6897 Remote Similarity NPD7741 Discontinued
0.689 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6883 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6882 Remote Similarity NPD6823 Phase 2
0.6879 Remote Similarity NPD3751 Discontinued
0.6879 Remote Similarity NPD2935 Discontinued
0.6875 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6871 Remote Similarity NPD3496 Discontinued
0.6865 Remote Similarity NPD6782 Approved
0.6865 Remote Similarity NPD6780 Approved
0.6865 Remote Similarity NPD6778 Approved
0.6865 Remote Similarity NPD6781 Approved
0.6865 Remote Similarity NPD6779 Approved
0.6865 Remote Similarity NPD6776 Approved
0.6865 Remote Similarity NPD6777 Approved
0.6853 Remote Similarity NPD2629 Approved
0.6845 Remote Similarity NPD7680 Approved
0.6829 Remote Similarity NPD7239 Suspended
0.6824 Remote Similarity NPD3705 Approved
0.6824 Remote Similarity NPD1610 Phase 2
0.6821 Remote Similarity NPD7473 Discontinued
0.6818 Remote Similarity NPD6233 Phase 2
0.6815 Remote Similarity NPD4108 Discontinued
0.6813 Remote Similarity NPD6213 Phase 3
0.6813 Remote Similarity NPD6212 Phase 3
0.6813 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6813 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6806 Remote Similarity NPD7874 Approved
0.6806 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6803 Remote Similarity NPD3019 Approved
0.6802 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6798 Remote Similarity NPD8407 Phase 2
0.6795 Remote Similarity NPD6653 Approved
0.6786 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6786 Remote Similarity NPD5402 Approved
0.6781 Remote Similarity NPD9545 Approved
0.6772 Remote Similarity NPD6100 Approved
0.6772 Remote Similarity NPD5408 Approved
0.6772 Remote Similarity NPD2438 Suspended
0.6772 Remote Similarity NPD5406 Approved
0.6772 Remote Similarity NPD5404 Approved
0.6772 Remote Similarity NPD6099 Approved
0.6772 Remote Similarity NPD5405 Approved
0.6771 Remote Similarity NPD7783 Phase 2
0.6771 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6766 Remote Similarity NPD6801 Discontinued
0.6761 Remote Similarity NPD969 Suspended
0.6755 Remote Similarity NPD7697 Approved
0.6755 Remote Similarity NPD7698 Approved
0.6755 Remote Similarity NPD7696 Phase 3
0.6754 Remote Similarity NPD8151 Discontinued
0.6753 Remote Similarity NPD6798 Discontinued
0.6752 Remote Similarity NPD4538 Approved
0.6752 Remote Similarity NPD4536 Approved
0.6752 Remote Similarity NPD4537 Clinical (unspecified phase)
0.675 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6747 Remote Similarity NPD6599 Discontinued
0.6746 Remote Similarity NPD7768 Phase 2
0.6744 Remote Similarity NPD6232 Discontinued
0.674 Remote Similarity NPD8361 Approved
0.674 Remote Similarity NPD8360 Approved
0.6738 Remote Similarity NPD3021 Approved
0.6738 Remote Similarity NPD3022 Approved
0.6735 Remote Similarity NPD1357 Approved
0.6733 Remote Similarity NPD5327 Phase 3
0.6733 Remote Similarity NPD4749 Approved
0.6732 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6731 Remote Similarity NPD4340 Discontinued
0.6731 Remote Similarity NPD230 Phase 1
0.673 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6726 Remote Similarity NPD2393 Clinical (unspecified phase)
0.672 Remote Similarity NPD7871 Phase 2
0.672 Remote Similarity NPD7870 Phase 2
0.6714 Remote Similarity NPD1358 Approved
0.6713 Remote Similarity NPD7635 Approved
0.6713 Remote Similarity NPD7843 Approved
0.6711 Remote Similarity NPD422 Phase 1
0.6708 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6708 Remote Similarity NPD4110 Phase 3
0.6707 Remote Similarity NPD7411 Suspended
0.6702 Remote Similarity NPD7701 Phase 2
0.6691 Remote Similarity NPD3020 Approved
0.6689 Remote Similarity NPD6696 Suspended
0.6688 Remote Similarity NPD4625 Phase 3
0.6687 Remote Similarity NPD2424 Discontinued
0.6684 Remote Similarity NPD7801 Approved
0.6667 Remote Similarity NPD5403 Approved
0.6667 Remote Similarity NPD1934 Approved
0.6667 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6166 Phase 2
0.6667 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6980 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data